Generation of a FRMD5 knockout human embryonic stem cell line by CRISPR/Cas9 editing

Jiaqi Fan1, Siyao Zhang1, Hairui Sun1

  • 1Maternal-Fetal Medicine Centre in Fetal Heart Disease, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China.

Stem Cell Research
|June 26, 2026
PubMed

Insights

Researchers created a FRMD5 knockout human embryonic stem cell line. This tool aids in studying FRMD5

Area of Science:

  • Genetics
  • Neuroscience
  • Developmental Biology

Background:

  • FRMD5 is a gene on chromosome 15q15.3 encoding a FERM domain protein.
  • Mutations in FRMD5 are associated with NEDEMA, a rare neurodevelopmental disorder.
  • NEDEMA presents with developmental delay, intellectual disability, ataxia, epilepsy, and abnormal eye movements.

Purpose of the Study:

  • To establish a human embryonic stem cell (hESC) model for FRMD5.
  • To create a tool for investigating the role of FRMD5 in neural development.

Main Methods:

  • CRISPR/Cas9 gene editing was used to create the FRMD5 knockout hESC line.
  • Standard cell culture techniques were employed to maintain pluripotency and assess differentiation potential.

Main Results:

  • A FRMD5 knockout (FRMD5-/-) hESC line was successfully established.
  • The FRMD5-/- hESC line maintained a normal karyotype.
  • The cell line expressed key pluripotency markers and differentiated into all three germ layers.

Conclusions:

  • The FRMD5-/- hESC line is a viable model for studying FRMD5 function.
  • This model will facilitate research into the genetic basis of NEDEMA and FRMD5-related neurodevelopmental disorders.